Currently out of the existing stock ratings of Yanan Zhu, 108 are a BUY (75.52%), 35 are a HOLD (24.48%).

Yanan Zhu

Work Performance Price Targets & Ratings Chart

Analyst Yanan Zhu, currently employed at WELLS FARGO, carries an average stock price target met ratio of 34.43% that have a potential upside of 29.38% achieved within 56 days.

Yanan Zhu’s has documented 288 price targets and ratings displayed on 35 stocks. The coverage is on Healthcare, Technology sectors.

Most recent stock forecast was given on IONS, Ionis Pharmaceuticals.

Wall Street Analyst Yanan Zhu

Analyst best performing recommendations are on VYGR (VOYAGER THERAPEUTICS).
The best stock recommendation documented was for VYGR (VOYAGER THERAPEUTICS) at 10/6/2021. The price target of $5 was fulfilled within 2 days with a profit of $1.13 (29.2%) receiving and performance score of 145.99.

Average potential price target upside

ARGX argenx NV ADR EDIT Editas Medicine RAPT RAPT Therapeutics AVRO AVROBIO BLUE Bluebird bio SGMO Sangamo Therapeutics AGLE Aeglea Bio Therapeutics AGTC Applied Genetic TSHA Taysha Gene Therapies BEAM Beam Therapeutics NTLA Intellia Therapeutics AFMD Affimed NV AUTL Autolus Therapeutics Ltd FATE Fate Therapeutics IOVA Iovance Biotherapeutics RNA Avidity Biosciences GRCL Gracell Biotechnologies TCRT Alaunos Therapeutics IONS Ionis Pharmaceuticals SYRE Spyre Therapeutics ARCT Arcturus Therapeutics Holdings CCXI ChemoCentryx MNTA Momenta Pharmaceuticals QURE Uniqure NV RGLS Regulus Therapeutics SRPT Sarepta Therapeutics VYGR Voyager Therapeutics ENGN enGene Holdings MGX Metagenomi NAMS NewAmsterdam Pharma Company N.V. BL Blackline CRSP Crispr Therapeutics AG CYTK Cytokinetics MORF Morphic PHVS Pharvaris BV

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 25-Apr-2023

$1232

$304.79 (32.87%)

$1182

15 days ago
(27-Oct-2026)

9/13 (69.23%)

$349.52 (39.61%)

214

Buy Since 17-Jul-2023

$1090

$162.79 (17.56%)

$1078

19 days ago
(23-Oct-2026)

5/9 (55.56%)

$216.29 (24.76%)

103

Buy Since 17-Jul-2023

$1120

$192.79 (20.79%)

$1185

19 days ago
(23-Oct-2026)

9/18 (50%)

$246.29 (28.19%)

119

Buy Since 18-Aug-2026

$1190

$262.79 (28.34%)

$1250

19 days ago
(23-Oct-2026)

0/3 (0%)

$316.29 (36.20%)

Buy Since 14-Sep-2018

$1336

$408.79 (44.09%)

$1356

19 days ago
(23-Oct-2026)

20/28 (71.43%)

$462.29 (52.91%)

198

Show more analysts

Please expand the browser size to see the chart

Which stock is Yanan Zhu most bullish on?

Potential upside of $53.3 has been obtained for QURE (UNIQURE NV)

Which stock is Yanan Zhu most reserved on?

Potential downside of $1.16 has been obtained for FATE (FATE THERAPEUTICS)

What Year was the first public recommendation made by Yanan Zhu?

On 2017
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?